nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—ABCC4—Fluorouracil—urinary bladder cancer	0.0706	0.0967	CbGbCtD
Rosuvastatin—ABCC1—Epirubicin—urinary bladder cancer	0.0608	0.0833	CbGbCtD
Rosuvastatin—ABCC1—Etoposide—urinary bladder cancer	0.0473	0.0649	CbGbCtD
Rosuvastatin—ABCB11—Doxorubicin—urinary bladder cancer	0.0455	0.0623	CbGbCtD
Rosuvastatin—SLCO1B3—Methotrexate—urinary bladder cancer	0.0452	0.062	CbGbCtD
Rosuvastatin—ABCC4—Methotrexate—urinary bladder cancer	0.0389	0.0533	CbGbCtD
Rosuvastatin—ABCG2—Fluorouracil—urinary bladder cancer	0.038	0.052	CbGbCtD
Rosuvastatin—ABCG2—Carboplatin—urinary bladder cancer	0.0377	0.0517	CbGbCtD
Rosuvastatin—ABCC1—Doxorubicin—urinary bladder cancer	0.0323	0.0443	CbGbCtD
Rosuvastatin—ABCG2—Cisplatin—urinary bladder cancer	0.0322	0.0442	CbGbCtD
Rosuvastatin—ABCG2—Etoposide—urinary bladder cancer	0.0317	0.0434	CbGbCtD
Rosuvastatin—ABCC1—Methotrexate—urinary bladder cancer	0.0313	0.0429	CbGbCtD
Rosuvastatin—SLCO1A2—Methotrexate—urinary bladder cancer	0.0279	0.0383	CbGbCtD
Rosuvastatin—SLCO1B1—Methotrexate—urinary bladder cancer	0.0263	0.0361	CbGbCtD
Rosuvastatin—ALB—Fluorouracil—urinary bladder cancer	0.0262	0.0359	CbGbCtD
Rosuvastatin—CYP3A4—Thiotepa—urinary bladder cancer	0.0252	0.0346	CbGbCtD
Rosuvastatin—ABCG2—Doxorubicin—urinary bladder cancer	0.0216	0.0296	CbGbCtD
Rosuvastatin—ABCG2—Methotrexate—urinary bladder cancer	0.0209	0.0287	CbGbCtD
Rosuvastatin—CYP3A5—Etoposide—urinary bladder cancer	0.0176	0.0241	CbGbCtD
Rosuvastatin—ALB—Methotrexate—urinary bladder cancer	0.0144	0.0198	CbGbCtD
Rosuvastatin—CYP2C9—Fluorouracil—urinary bladder cancer	0.0141	0.0193	CbGbCtD
Rosuvastatin—CYP2C9—Cisplatin—urinary bladder cancer	0.012	0.0164	CbGbCtD
Rosuvastatin—CYP3A4—Etoposide—urinary bladder cancer	0.00684	0.00938	CbGbCtD
Rosuvastatin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00467	0.0064	CbGbCtD
Rosuvastatin—Pitavastatin—UGT2B7—urinary bladder cancer	0.00437	0.519	CrCbGaD
Rosuvastatin—Fluvastatin—UGT2B7—urinary bladder cancer	0.00405	0.48	CrCbGaD
Rosuvastatin—CYP2C19—urine—urinary bladder cancer	0.00389	0.0667	CbGeAlD
Rosuvastatin—CYP2C9—urine—urinary bladder cancer	0.00302	0.0517	CbGeAlD
Rosuvastatin—SLC7A11—smooth muscle tissue—urinary bladder cancer	0.00255	0.0437	CbGeAlD
Rosuvastatin—SLC7A11—renal system—urinary bladder cancer	0.00245	0.0421	CbGeAlD
Rosuvastatin—CYP3A4—urine—urinary bladder cancer	0.0023	0.0395	CbGeAlD
Rosuvastatin—HMGCR—prostate gland—urinary bladder cancer	0.00224	0.0384	CbGeAlD
Rosuvastatin—SLC7A11—female reproductive system—urinary bladder cancer	0.00196	0.0337	CbGeAlD
Rosuvastatin—SLCO2B1—prostate gland—urinary bladder cancer	0.0019	0.0325	CbGeAlD
Rosuvastatin—HMGCR—seminal vesicle—urinary bladder cancer	0.00189	0.0325	CbGeAlD
Rosuvastatin—SLCO1B3—vagina—urinary bladder cancer	0.00183	0.0314	CbGeAlD
Rosuvastatin—ABCC4—prostate gland—urinary bladder cancer	0.00168	0.0288	CbGeAlD
Rosuvastatin—HMGCR—epithelium—urinary bladder cancer	0.00164	0.0282	CbGeAlD
Rosuvastatin—HMGCR—smooth muscle tissue—urinary bladder cancer	0.00158	0.0272	CbGeAlD
Rosuvastatin—HMGCR—renal system—urinary bladder cancer	0.00152	0.0262	CbGeAlD
Rosuvastatin—HMGCR—urethra—urinary bladder cancer	0.0015	0.0257	CbGeAlD
Rosuvastatin—SLCO1B1—renal system—urinary bladder cancer	0.00146	0.0251	CbGeAlD
Rosuvastatin—ABCC1—prostate gland—urinary bladder cancer	0.00143	0.0246	CbGeAlD
Rosuvastatin—SLCO2B1—renal system—urinary bladder cancer	0.00129	0.0222	CbGeAlD
Rosuvastatin—HMGCR—female reproductive system—urinary bladder cancer	0.00122	0.021	CbGeAlD
Rosuvastatin—ABCC1—seminal vesicle—urinary bladder cancer	0.00121	0.0208	CbGeAlD
Rosuvastatin—SLCO1A2—renal system—urinary bladder cancer	0.00119	0.0204	CbGeAlD
Rosuvastatin—ABCG2—prostate gland—urinary bladder cancer	0.00118	0.0203	CbGeAlD
Rosuvastatin—SLCO1B1—female reproductive system—urinary bladder cancer	0.00117	0.0201	CbGeAlD
Rosuvastatin—ABCC4—renal system—urinary bladder cancer	0.00114	0.0196	CbGeAlD
Rosuvastatin—HMGCR—vagina—urinary bladder cancer	0.0011	0.0189	CbGeAlD
Rosuvastatin—CYP3A5—prostate gland—urinary bladder cancer	0.0011	0.0189	CbGeAlD
Rosuvastatin—SLCO2B1—female reproductive system—urinary bladder cancer	0.00103	0.0178	CbGeAlD
Rosuvastatin—ABCG2—seminal vesicle—urinary bladder cancer	0.001	0.0172	CbGeAlD
Rosuvastatin—ABCC1—urethra—urinary bladder cancer	0.000958	0.0164	CbGeAlD
Rosuvastatin—ABCC4—female reproductive system—urinary bladder cancer	0.000916	0.0157	CbGeAlD
Rosuvastatin—ABCG2—urethra—urinary bladder cancer	0.000793	0.0136	CbGeAlD
Rosuvastatin—CYP3A5—renal system—urinary bladder cancer	0.00075	0.0129	CbGeAlD
Rosuvastatin—HMGCR—lymph node—urinary bladder cancer	0.000714	0.0123	CbGeAlD
Rosuvastatin—ABCC1—vagina—urinary bladder cancer	0.000707	0.0121	CbGeAlD
Rosuvastatin—CYP2C19—vagina—urinary bladder cancer	0.000689	0.0118	CbGeAlD
Rosuvastatin—SLCO2B1—lymph node—urinary bladder cancer	0.000605	0.0104	CbGeAlD
Rosuvastatin—CYP2C9—female reproductive system—urinary bladder cancer	0.000591	0.0101	CbGeAlD
Rosuvastatin—ABCG2—vagina—urinary bladder cancer	0.000585	0.01	CbGeAlD
Rosuvastatin—CYP3A4—renal system—urinary bladder cancer	0.000563	0.00965	CbGeAlD
Rosuvastatin—ALB—lymph node—urinary bladder cancer	0.000554	0.0095	CbGeAlD
Rosuvastatin—CYP3A5—vagina—urinary bladder cancer	0.000543	0.00932	CbGeAlD
Rosuvastatin—ABCC4—lymph node—urinary bladder cancer	0.000536	0.0092	CbGeAlD
Rosuvastatin—Blood disorder—Doxorubicin—urinary bladder cancer	0.000468	0.0041	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.000467	0.0041	CcSEcCtD
Rosuvastatin—Headache—Mitomycin—urinary bladder cancer	0.000467	0.00409	CcSEcCtD
Rosuvastatin—Mental disorder—Thiotepa—urinary bladder cancer	0.000462	0.00405	CcSEcCtD
Rosuvastatin—Cough increased—Epirubicin—urinary bladder cancer	0.000462	0.00405	CcSEcCtD
Rosuvastatin—ABCC1—lymph node—urinary bladder cancer	0.000457	0.00784	CbGeAlD
Rosuvastatin—Sinusitis—Fluorouracil—urinary bladder cancer	0.000456	0.00399	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.000452	0.00396	CcSEcCtD
Rosuvastatin—CYP3A4—female reproductive system—urinary bladder cancer	0.000451	0.00773	CbGeAlD
Rosuvastatin—Rhinitis—Gemcitabine—urinary bladder cancer	0.000445	0.0039	CcSEcCtD
Rosuvastatin—Nausea—Mitomycin—urinary bladder cancer	0.000443	0.00388	CcSEcCtD
Rosuvastatin—Pharyngitis—Gemcitabine—urinary bladder cancer	0.00044	0.00386	CcSEcCtD
Rosuvastatin—Rhinitis—Fluorouracil—urinary bladder cancer	0.000437	0.00383	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.000436	0.00382	CcSEcCtD
Rosuvastatin—Pharyngitis—Fluorouracil—urinary bladder cancer	0.000433	0.00379	CcSEcCtD
Rosuvastatin—Cough increased—Doxorubicin—urinary bladder cancer	0.000427	0.00374	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.000414	0.00362	CcSEcCtD
Rosuvastatin—Jaundice—Etoposide—urinary bladder cancer	0.000411	0.0036	CcSEcCtD
Rosuvastatin—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000404	0.00354	CcSEcCtD
Rosuvastatin—Cough—Thiotepa—urinary bladder cancer	0.000401	0.00351	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.000399	0.0035	CcSEcCtD
Rosuvastatin—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000396	0.00347	CcSEcCtD
Rosuvastatin—Myalgia—Thiotepa—urinary bladder cancer	0.000391	0.00342	CcSEcCtD
Rosuvastatin—Arthralgia—Thiotepa—urinary bladder cancer	0.000391	0.00342	CcSEcCtD
Rosuvastatin—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00039	0.00341	CcSEcCtD
Rosuvastatin—ABCG2—lymph node—urinary bladder cancer	0.000378	0.00649	CbGeAlD
Rosuvastatin—Confusional state—Thiotepa—urinary bladder cancer	0.000378	0.00331	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.000377	0.0033	CcSEcCtD
Rosuvastatin—Infection—Thiotepa—urinary bladder cancer	0.000372	0.00326	CcSEcCtD
Rosuvastatin—Hypertonia—Epirubicin—urinary bladder cancer	0.000371	0.00325	CcSEcCtD
Rosuvastatin—Arrhythmia—Cisplatin—urinary bladder cancer	0.000369	0.00324	CcSEcCtD
Rosuvastatin—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000367	0.00322	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000367	0.00321	CcSEcCtD
Rosuvastatin—Hepatic failure—Methotrexate—urinary bladder cancer	0.000365	0.0032	CcSEcCtD
Rosuvastatin—Renal failure acute—Methotrexate—urinary bladder cancer	0.000355	0.00311	CcSEcCtD
Rosuvastatin—Flatulence—Cisplatin—urinary bladder cancer	0.000355	0.00311	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.000353	0.00309	CcSEcCtD
Rosuvastatin—Hypertonia—Doxorubicin—urinary bladder cancer	0.000343	0.00301	CcSEcCtD
Rosuvastatin—Hepatic failure—Epirubicin—urinary bladder cancer	0.000342	0.00299	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000341	0.00299	CcSEcCtD
Rosuvastatin—Cough—Gemcitabine—urinary bladder cancer	0.000337	0.00295	CcSEcCtD
Rosuvastatin—Paraesthesia—Thiotepa—urinary bladder cancer	0.000336	0.00295	CcSEcCtD
Rosuvastatin—Renal failure acute—Epirubicin—urinary bladder cancer	0.000332	0.00291	CcSEcCtD
Rosuvastatin—Dyspepsia—Thiotepa—urinary bladder cancer	0.00033	0.00289	CcSEcCtD
Rosuvastatin—Arthralgia—Gemcitabine—urinary bladder cancer	0.000329	0.00288	CcSEcCtD
Rosuvastatin—Myalgia—Gemcitabine—urinary bladder cancer	0.000329	0.00288	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.000327	0.00286	CcSEcCtD
Rosuvastatin—Myalgia—Fluorouracil—urinary bladder cancer	0.000323	0.00283	CcSEcCtD
Rosuvastatin—Pain—Thiotepa—urinary bladder cancer	0.00032	0.00281	CcSEcCtD
Rosuvastatin—Constipation—Thiotepa—urinary bladder cancer	0.00032	0.00281	CcSEcCtD
Rosuvastatin—Hepatic failure—Doxorubicin—urinary bladder cancer	0.000316	0.00277	CcSEcCtD
Rosuvastatin—Infection—Gemcitabine—urinary bladder cancer	0.000313	0.00274	CcSEcCtD
Rosuvastatin—Confusional state—Fluorouracil—urinary bladder cancer	0.000312	0.00274	CcSEcCtD
Rosuvastatin—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000309	0.00271	CcSEcCtD
Rosuvastatin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000309	0.00271	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000309	0.0027	CcSEcCtD
Rosuvastatin—Infection—Fluorouracil—urinary bladder cancer	0.000308	0.0027	CcSEcCtD
Rosuvastatin—Renal failure acute—Doxorubicin—urinary bladder cancer	0.000308	0.0027	CcSEcCtD
Rosuvastatin—Myalgia—Cisplatin—urinary bladder cancer	0.000306	0.00269	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000306	0.00268	CcSEcCtD
Rosuvastatin—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000304	0.00266	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000303	0.00266	CcSEcCtD
Rosuvastatin—Urticaria—Thiotepa—urinary bladder cancer	0.000298	0.00261	CcSEcCtD
Rosuvastatin—Breast disorder—Methotrexate—urinary bladder cancer	0.000296	0.0026	CcSEcCtD
Rosuvastatin—Abdominal pain—Thiotepa—urinary bladder cancer	0.000296	0.0026	CcSEcCtD
Rosuvastatin—Infection—Cisplatin—urinary bladder cancer	0.000292	0.00256	CcSEcCtD
Rosuvastatin—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000288	0.00252	CcSEcCtD
Rosuvastatin—Cough—Etoposide—urinary bladder cancer	0.000288	0.00252	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000288	0.00252	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000287	0.00252	CcSEcCtD
Rosuvastatin—Insomnia—Gemcitabine—urinary bladder cancer	0.000285	0.0025	CcSEcCtD
Rosuvastatin—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000283	0.00248	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000282	0.00247	CcSEcCtD
Rosuvastatin—Insomnia—Fluorouracil—urinary bladder cancer	0.00028	0.00246	CcSEcCtD
Rosuvastatin—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000278	0.00244	CcSEcCtD
Rosuvastatin—Pancreatitis—Methotrexate—urinary bladder cancer	0.000278	0.00244	CcSEcCtD
Rosuvastatin—Breast disorder—Epirubicin—urinary bladder cancer	0.000277	0.00243	CcSEcCtD
Rosuvastatin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000276	0.00242	CcSEcCtD
Rosuvastatin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000273	0.00239	CcSEcCtD
Rosuvastatin—Confusional state—Etoposide—urinary bladder cancer	0.000271	0.00238	CcSEcCtD
Rosuvastatin—Muscular weakness—Epirubicin—urinary bladder cancer	0.000271	0.00237	CcSEcCtD
Rosuvastatin—Constipation—Gemcitabine—urinary bladder cancer	0.00027	0.00236	CcSEcCtD
Rosuvastatin—Pain—Gemcitabine—urinary bladder cancer	0.00027	0.00236	CcSEcCtD
Rosuvastatin—Asthenia—Thiotepa—urinary bladder cancer	0.000269	0.00236	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000268	0.00235	CcSEcCtD
Rosuvastatin—Infection—Etoposide—urinary bladder cancer	0.000267	0.00234	CcSEcCtD
Rosuvastatin—Influenza—Epirubicin—urinary bladder cancer	0.000265	0.00232	CcSEcCtD
Rosuvastatin—Pruritus—Thiotepa—urinary bladder cancer	0.000265	0.00232	CcSEcCtD
Rosuvastatin—Pain—Fluorouracil—urinary bladder cancer	0.000265	0.00232	CcSEcCtD
Rosuvastatin—Paraesthesia—Cisplatin—urinary bladder cancer	0.000264	0.00231	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000264	0.00231	CcSEcCtD
Rosuvastatin—Pancreatitis—Epirubicin—urinary bladder cancer	0.00026	0.00228	CcSEcCtD
Rosuvastatin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00026	0.00228	CcSEcCtD
Rosuvastatin—Breast disorder—Doxorubicin—urinary bladder cancer	0.000257	0.00225	CcSEcCtD
Rosuvastatin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000256	0.00225	CcSEcCtD
Rosuvastatin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000255	0.00224	CcSEcCtD
Rosuvastatin—Bronchitis—Epirubicin—urinary bladder cancer	0.000255	0.00224	CcSEcCtD
Rosuvastatin—Depression—Methotrexate—urinary bladder cancer	0.000252	0.00221	CcSEcCtD
Rosuvastatin—Pain—Cisplatin—urinary bladder cancer	0.000251	0.0022	CcSEcCtD
Rosuvastatin—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00025	0.00219	CcSEcCtD
Rosuvastatin—Dizziness—Thiotepa—urinary bladder cancer	0.000248	0.00217	CcSEcCtD
Rosuvastatin—Urticaria—Fluorouracil—urinary bladder cancer	0.000246	0.00216	CcSEcCtD
Rosuvastatin—Influenza—Doxorubicin—urinary bladder cancer	0.000245	0.00215	CcSEcCtD
Rosuvastatin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000242	0.00212	CcSEcCtD
Rosuvastatin—Paraesthesia—Etoposide—urinary bladder cancer	0.000242	0.00212	CcSEcCtD
Rosuvastatin—Haematuria—Methotrexate—urinary bladder cancer	0.000241	0.00211	CcSEcCtD
Rosuvastatin—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000241	0.00211	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000239	0.00209	CcSEcCtD
Rosuvastatin—Rash—Thiotepa—urinary bladder cancer	0.000236	0.00207	CcSEcCtD
Rosuvastatin—Bronchitis—Doxorubicin—urinary bladder cancer	0.000236	0.00207	CcSEcCtD
Rosuvastatin—Dermatitis—Thiotepa—urinary bladder cancer	0.000236	0.00207	CcSEcCtD
Rosuvastatin—Headache—Thiotepa—urinary bladder cancer	0.000235	0.00206	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000232	0.00203	CcSEcCtD
Rosuvastatin—Jaundice—Epirubicin—urinary bladder cancer	0.000231	0.00202	CcSEcCtD
Rosuvastatin—Constipation—Etoposide—urinary bladder cancer	0.00023	0.00202	CcSEcCtD
Rosuvastatin—Pain—Etoposide—urinary bladder cancer	0.00023	0.00202	CcSEcCtD
Rosuvastatin—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00023	0.00201	CcSEcCtD
Rosuvastatin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000228	0.002	CcSEcCtD
Rosuvastatin—Hepatitis—Methotrexate—urinary bladder cancer	0.000227	0.00199	CcSEcCtD
Rosuvastatin—Asthenia—Gemcitabine—urinary bladder cancer	0.000226	0.00198	CcSEcCtD
Rosuvastatin—Haematuria—Epirubicin—urinary bladder cancer	0.000226	0.00198	CcSEcCtD
Rosuvastatin—Pharyngitis—Methotrexate—urinary bladder cancer	0.000225	0.00197	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000224	0.00196	CcSEcCtD
Rosuvastatin—Pruritus—Gemcitabine—urinary bladder cancer	0.000223	0.00195	CcSEcCtD
Rosuvastatin—Nausea—Thiotepa—urinary bladder cancer	0.000223	0.00195	CcSEcCtD
Rosuvastatin—Sinusitis—Epirubicin—urinary bladder cancer	0.000222	0.00194	CcSEcCtD
Rosuvastatin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000222	0.00194	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00022	0.00193	CcSEcCtD
Rosuvastatin—Pruritus—Fluorouracil—urinary bladder cancer	0.000219	0.00192	CcSEcCtD
Rosuvastatin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000216	0.0019	CcSEcCtD
Rosuvastatin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000216	0.00189	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000215	0.00188	CcSEcCtD
Rosuvastatin—Urticaria—Etoposide—urinary bladder cancer	0.000214	0.00187	CcSEcCtD
Rosuvastatin—Jaundice—Doxorubicin—urinary bladder cancer	0.000213	0.00187	CcSEcCtD
Rosuvastatin—Rhinitis—Epirubicin—urinary bladder cancer	0.000213	0.00187	CcSEcCtD
Rosuvastatin—Abdominal pain—Etoposide—urinary bladder cancer	0.000213	0.00186	CcSEcCtD
Rosuvastatin—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000213	0.00186	CcSEcCtD
Rosuvastatin—Hepatitis—Epirubicin—urinary bladder cancer	0.000212	0.00186	CcSEcCtD
Rosuvastatin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000212	0.00186	CcSEcCtD
Rosuvastatin—Asthenia—Cisplatin—urinary bladder cancer	0.000211	0.00185	CcSEcCtD
Rosuvastatin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000211	0.00185	CcSEcCtD
Rosuvastatin—Haematuria—Doxorubicin—urinary bladder cancer	0.000209	0.00183	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000207	0.00181	CcSEcCtD
Rosuvastatin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000205	0.0018	CcSEcCtD
Rosuvastatin—Dizziness—Fluorouracil—urinary bladder cancer	0.000205	0.0018	CcSEcCtD
Rosuvastatin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000201	0.00176	CcSEcCtD
Rosuvastatin—Mental disorder—Methotrexate—urinary bladder cancer	0.000199	0.00174	CcSEcCtD
Rosuvastatin—Rash—Gemcitabine—urinary bladder cancer	0.000199	0.00174	CcSEcCtD
Rosuvastatin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000199	0.00174	CcSEcCtD
Rosuvastatin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000198	0.00174	CcSEcCtD
Rosuvastatin—Headache—Gemcitabine—urinary bladder cancer	0.000197	0.00173	CcSEcCtD
Rosuvastatin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000197	0.00173	CcSEcCtD
Rosuvastatin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000196	0.00172	CcSEcCtD
Rosuvastatin—Rash—Fluorouracil—urinary bladder cancer	0.000195	0.00171	CcSEcCtD
Rosuvastatin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000195	0.00171	CcSEcCtD
Rosuvastatin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000195	0.00171	CcSEcCtD
Rosuvastatin—Headache—Fluorouracil—urinary bladder cancer	0.000194	0.0017	CcSEcCtD
Rosuvastatin—Asthenia—Etoposide—urinary bladder cancer	0.000193	0.00169	CcSEcCtD
Rosuvastatin—Pruritus—Etoposide—urinary bladder cancer	0.00019	0.00167	CcSEcCtD
Rosuvastatin—Arrhythmia—Epirubicin—urinary bladder cancer	0.00019	0.00166	CcSEcCtD
Rosuvastatin—Nausea—Gemcitabine—urinary bladder cancer	0.000187	0.00164	CcSEcCtD
Rosuvastatin—Mental disorder—Epirubicin—urinary bladder cancer	0.000186	0.00163	CcSEcCtD
Rosuvastatin—Rash—Cisplatin—urinary bladder cancer	0.000185	0.00162	CcSEcCtD
Rosuvastatin—Dermatitis—Cisplatin—urinary bladder cancer	0.000185	0.00162	CcSEcCtD
Rosuvastatin—Diarrhoea—Etoposide—urinary bladder cancer	0.000184	0.00161	CcSEcCtD
Rosuvastatin—Nausea—Fluorouracil—urinary bladder cancer	0.000184	0.00161	CcSEcCtD
Rosuvastatin—Flatulence—Epirubicin—urinary bladder cancer	0.000182	0.0016	CcSEcCtD
Rosuvastatin—Dizziness—Etoposide—urinary bladder cancer	0.000178	0.00156	CcSEcCtD
Rosuvastatin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000176	0.00154	CcSEcCtD
Rosuvastatin—Nausea—Cisplatin—urinary bladder cancer	0.000174	0.00153	CcSEcCtD
Rosuvastatin—Cough—Methotrexate—urinary bladder cancer	0.000172	0.00151	CcSEcCtD
Rosuvastatin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000172	0.00151	CcSEcCtD
Rosuvastatin—Rash—Etoposide—urinary bladder cancer	0.00017	0.00149	CcSEcCtD
Rosuvastatin—Dermatitis—Etoposide—urinary bladder cancer	0.00017	0.00149	CcSEcCtD
Rosuvastatin—Headache—Etoposide—urinary bladder cancer	0.000169	0.00148	CcSEcCtD
Rosuvastatin—Flatulence—Doxorubicin—urinary bladder cancer	0.000169	0.00148	CcSEcCtD
Rosuvastatin—Arthralgia—Methotrexate—urinary bladder cancer	0.000168	0.00147	CcSEcCtD
Rosuvastatin—Myalgia—Methotrexate—urinary bladder cancer	0.000168	0.00147	CcSEcCtD
Rosuvastatin—Confusional state—Methotrexate—urinary bladder cancer	0.000163	0.00142	CcSEcCtD
Rosuvastatin—Cough—Epirubicin—urinary bladder cancer	0.000161	0.00141	CcSEcCtD
Rosuvastatin—Infection—Methotrexate—urinary bladder cancer	0.00016	0.0014	CcSEcCtD
Rosuvastatin—Nausea—Etoposide—urinary bladder cancer	0.00016	0.0014	CcSEcCtD
Rosuvastatin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000158	0.00139	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000158	0.00138	CcSEcCtD
Rosuvastatin—Arthralgia—Epirubicin—urinary bladder cancer	0.000157	0.00138	CcSEcCtD
Rosuvastatin—Myalgia—Epirubicin—urinary bladder cancer	0.000157	0.00138	CcSEcCtD
Rosuvastatin—Confusional state—Epirubicin—urinary bladder cancer	0.000152	0.00133	CcSEcCtD
Rosuvastatin—Infection—Epirubicin—urinary bladder cancer	0.00015	0.00131	CcSEcCtD
Rosuvastatin—Cough—Doxorubicin—urinary bladder cancer	0.000149	0.00131	CcSEcCtD
Rosuvastatin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000148	0.0013	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000148	0.00129	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000147	0.00129	CcSEcCtD
Rosuvastatin—Insomnia—Methotrexate—urinary bladder cancer	0.000146	0.00128	CcSEcCtD
Rosuvastatin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000146	0.00128	CcSEcCtD
Rosuvastatin—Myalgia—Doxorubicin—urinary bladder cancer	0.000146	0.00128	CcSEcCtD
Rosuvastatin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000145	0.00127	CcSEcCtD
Rosuvastatin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000142	0.00124	CcSEcCtD
Rosuvastatin—Confusional state—Doxorubicin—urinary bladder cancer	0.000141	0.00123	CcSEcCtD
Rosuvastatin—Infection—Doxorubicin—urinary bladder cancer	0.000139	0.00122	CcSEcCtD
Rosuvastatin—Pain—Methotrexate—urinary bladder cancer	0.000138	0.00121	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000137	0.0012	CcSEcCtD
Rosuvastatin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000137	0.0012	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000137	0.0012	CcSEcCtD
Rosuvastatin—Insomnia—Epirubicin—urinary bladder cancer	0.000136	0.0012	CcSEcCtD
Rosuvastatin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000135	0.00119	CcSEcCtD
Rosuvastatin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000133	0.00116	CcSEcCtD
Rosuvastatin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000133	0.00116	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000132	0.00116	CcSEcCtD
Rosuvastatin—Pain—Epirubicin—urinary bladder cancer	0.000129	0.00113	CcSEcCtD
Rosuvastatin—Constipation—Epirubicin—urinary bladder cancer	0.000129	0.00113	CcSEcCtD
Rosuvastatin—Urticaria—Methotrexate—urinary bladder cancer	0.000128	0.00112	CcSEcCtD
Rosuvastatin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000127	0.00112	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000127	0.00111	CcSEcCtD
Rosuvastatin—Insomnia—Doxorubicin—urinary bladder cancer	0.000126	0.00111	CcSEcCtD
Rosuvastatin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000125	0.0011	CcSEcCtD
Rosuvastatin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000124	0.00109	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000123	0.00108	CcSEcCtD
Rosuvastatin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000123	0.00108	CcSEcCtD
Rosuvastatin—Urticaria—Epirubicin—urinary bladder cancer	0.00012	0.00105	CcSEcCtD
Rosuvastatin—Pain—Doxorubicin—urinary bladder cancer	0.000119	0.00105	CcSEcCtD
Rosuvastatin—Constipation—Doxorubicin—urinary bladder cancer	0.000119	0.00105	CcSEcCtD
Rosuvastatin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000119	0.00104	CcSEcCtD
Rosuvastatin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000119	0.00104	CcSEcCtD
Rosuvastatin—Asthenia—Methotrexate—urinary bladder cancer	0.000116	0.00101	CcSEcCtD
Rosuvastatin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000115	0.00101	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000114	0.001	CcSEcCtD
Rosuvastatin—Pruritus—Methotrexate—urinary bladder cancer	0.000114	0.000999	CcSEcCtD
Rosuvastatin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000111	0.000974	CcSEcCtD
Rosuvastatin—Urticaria—Doxorubicin—urinary bladder cancer	0.000111	0.000972	CcSEcCtD
Rosuvastatin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00011	0.000967	CcSEcCtD
Rosuvastatin—Diarrhoea—Methotrexate—urinary bladder cancer	0.00011	0.000966	CcSEcCtD
Rosuvastatin—Asthenia—Epirubicin—urinary bladder cancer	0.000108	0.000948	CcSEcCtD
Rosuvastatin—Pruritus—Epirubicin—urinary bladder cancer	0.000107	0.000935	CcSEcCtD
Rosuvastatin—Dizziness—Methotrexate—urinary bladder cancer	0.000107	0.000934	CcSEcCtD
Rosuvastatin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000103	0.000904	CcSEcCtD
Rosuvastatin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000103	0.000901	CcSEcCtD
Rosuvastatin—Rash—Methotrexate—urinary bladder cancer	0.000102	0.000891	CcSEcCtD
Rosuvastatin—Dermatitis—Methotrexate—urinary bladder cancer	0.000102	0.00089	CcSEcCtD
Rosuvastatin—Headache—Methotrexate—urinary bladder cancer	0.000101	0.000885	CcSEcCtD
Rosuvastatin—Asthenia—Doxorubicin—urinary bladder cancer	0.0001	0.000878	CcSEcCtD
Rosuvastatin—Dizziness—Epirubicin—urinary bladder cancer	9.98e-05	0.000874	CcSEcCtD
Rosuvastatin—Pruritus—Doxorubicin—urinary bladder cancer	9.88e-05	0.000865	CcSEcCtD
Rosuvastatin—Nausea—Methotrexate—urinary bladder cancer	9.58e-05	0.000839	CcSEcCtD
Rosuvastatin—Diarrhoea—Doxorubicin—urinary bladder cancer	9.55e-05	0.000837	CcSEcCtD
Rosuvastatin—Rash—Epirubicin—urinary bladder cancer	9.51e-05	0.000833	CcSEcCtD
Rosuvastatin—Dermatitis—Epirubicin—urinary bladder cancer	9.5e-05	0.000833	CcSEcCtD
Rosuvastatin—Headache—Epirubicin—urinary bladder cancer	9.45e-05	0.000828	CcSEcCtD
Rosuvastatin—Dizziness—Doxorubicin—urinary bladder cancer	9.23e-05	0.000809	CcSEcCtD
Rosuvastatin—Nausea—Epirubicin—urinary bladder cancer	8.96e-05	0.000785	CcSEcCtD
Rosuvastatin—Rash—Doxorubicin—urinary bladder cancer	8.8e-05	0.000771	CcSEcCtD
Rosuvastatin—Dermatitis—Doxorubicin—urinary bladder cancer	8.79e-05	0.00077	CcSEcCtD
Rosuvastatin—Headache—Doxorubicin—urinary bladder cancer	8.74e-05	0.000766	CcSEcCtD
Rosuvastatin—Nausea—Doxorubicin—urinary bladder cancer	8.29e-05	0.000727	CcSEcCtD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.56e-05	0.000286	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.55e-05	0.000285	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	2.55e-05	0.000285	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.54e-05	0.000284	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—EP300—urinary bladder cancer	2.53e-05	0.000282	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—GSTT1—urinary bladder cancer	2.52e-05	0.000281	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	2.49e-05	0.000277	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.47e-05	0.000276	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	2.47e-05	0.000275	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	2.46e-05	0.000275	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—SRC—urinary bladder cancer	2.46e-05	0.000274	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—TYMS—urinary bladder cancer	2.45e-05	0.000274	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—NCOR1—urinary bladder cancer	2.42e-05	0.00027	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—GSTM1—urinary bladder cancer	2.42e-05	0.00027	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	2.42e-05	0.00027	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PPARG—urinary bladder cancer	2.4e-05	0.000268	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—NQO1—urinary bladder cancer	2.38e-05	0.000265	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.36e-05	0.000263	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	2.33e-05	0.000259	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—NAT2—urinary bladder cancer	2.32e-05	0.000259	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—GPX1—urinary bladder cancer	2.32e-05	0.000259	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—CREBBP—urinary bladder cancer	2.31e-05	0.000258	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.3e-05	0.000257	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—ERCC2—urinary bladder cancer	2.28e-05	0.000254	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	2.28e-05	0.000254	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	2.27e-05	0.000253	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	2.26e-05	0.000252	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.23e-05	0.000249	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.22e-05	0.000248	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—TYMP—urinary bladder cancer	2.21e-05	0.000247	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	2.2e-05	0.000246	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.19e-05	0.000244	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—NCOR1—urinary bladder cancer	2.17e-05	0.000243	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	2.16e-05	0.000241	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—MTHFR—urinary bladder cancer	2.14e-05	0.000239	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.13e-05	0.000238	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.13e-05	0.000237	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—NQO1—urinary bladder cancer	2.09e-05	0.000233	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.08e-05	0.000232	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	2.05e-05	0.000228	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—ERCC2—urinary bladder cancer	2.04e-05	0.000228	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PLAU—urinary bladder cancer	2.04e-05	0.000227	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—KRAS—urinary bladder cancer	2.03e-05	0.000227	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	2.02e-05	0.000226	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	2.02e-05	0.000226	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.01e-05	0.000224	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	2.01e-05	0.000224	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—NAT2—urinary bladder cancer	2e-05	0.000223	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.99e-05	0.000222	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—TYMP—urinary bladder cancer	1.99e-05	0.000222	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—GSTP1—urinary bladder cancer	1.98e-05	0.000221	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.97e-05	0.00022	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.97e-05	0.00022	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	1.94e-05	0.000216	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MTHFR—urinary bladder cancer	1.92e-05	0.000214	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.92e-05	0.000214	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—TERT—urinary bladder cancer	1.92e-05	0.000214	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.91e-05	0.000213	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.91e-05	0.000213	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	1.9e-05	0.000212	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PTGS2—urinary bladder cancer	1.89e-05	0.000211	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	1.88e-05	0.00021	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.86e-05	0.000207	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.86e-05	0.000207	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	1.85e-05	0.000206	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—TYMS—urinary bladder cancer	1.84e-05	0.000206	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.82e-05	0.000203	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—GSTM1—urinary bladder cancer	1.82e-05	0.000203	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—NCOR1—urinary bladder cancer	1.82e-05	0.000203	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.82e-05	0.000203	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.81e-05	0.000202	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—TP53—urinary bladder cancer	1.81e-05	0.000202	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.8e-05	0.000201	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.8e-05	0.000201	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.8e-05	0.000201	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	1.79e-05	0.0002	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	1.77e-05	0.000198	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—FGFR3—urinary bladder cancer	1.76e-05	0.000196	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	1.75e-05	0.000195	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—GPX1—urinary bladder cancer	1.74e-05	0.000195	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—GSTP1—urinary bladder cancer	1.74e-05	0.000195	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.74e-05	0.000194	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PPARG—urinary bladder cancer	1.74e-05	0.000194	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	1.73e-05	0.000193	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	1.73e-05	0.000193	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—HRAS—urinary bladder cancer	1.73e-05	0.000193	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—RRM2—urinary bladder cancer	1.73e-05	0.000193	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—ERCC2—urinary bladder cancer	1.71e-05	0.000191	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.68e-05	0.000187	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—CREBBP—urinary bladder cancer	1.67e-05	0.000186	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—IGF1—urinary bladder cancer	1.66e-05	0.000185	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	1.66e-05	0.000185	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PTEN—urinary bladder cancer	1.65e-05	0.000184	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.64e-05	0.000183	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.63e-05	0.000182	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.62e-05	0.000181	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.62e-05	0.000181	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—MTHFR—urinary bladder cancer	1.61e-05	0.00018	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1.6e-05	0.000179	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1.6e-05	0.000179	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—ENO2—urinary bladder cancer	1.6e-05	0.000179	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—HPGDS—urinary bladder cancer	1.6e-05	0.000179	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.59e-05	0.000178	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—EP300—urinary bladder cancer	1.57e-05	0.000175	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GSTT1—urinary bladder cancer	1.55e-05	0.000173	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.55e-05	0.000173	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—GPX1—urinary bladder cancer	1.53e-05	0.000171	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.53e-05	0.000171	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.53e-05	0.000171	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.53e-05	0.000171	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—RHOA—urinary bladder cancer	1.52e-05	0.000169	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—ERCC2—urinary bladder cancer	1.51e-05	0.000168	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.5e-05	0.000167	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CREBBP—urinary bladder cancer	1.5e-05	0.000167	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.49e-05	0.000167	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.45e-05	0.000162	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	1.45e-05	0.000162	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.45e-05	0.000162	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.44e-05	0.00016	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.44e-05	0.00016	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.43e-05	0.000159	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—MTHFR—urinary bladder cancer	1.42e-05	0.000158	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.41e-05	0.000158	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.39e-05	0.000155	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.39e-05	0.000155	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.37e-05	0.000153	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PTGS2—urinary bladder cancer	1.37e-05	0.000152	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—RHOA—urinary bladder cancer	1.35e-05	0.000151	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.31e-05	0.000146	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.31e-05	0.000146	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PPARG—urinary bladder cancer	1.3e-05	0.000146	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.3e-05	0.000145	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—NQO1—urinary bladder cancer	1.29e-05	0.000144	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—IL2—urinary bladder cancer	1.27e-05	0.000142	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.27e-05	0.000142	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	1.27e-05	0.000141	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CREBBP—urinary bladder cancer	1.25e-05	0.00014	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—ERBB2—urinary bladder cancer	1.25e-05	0.00014	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.25e-05	0.00014	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.25e-05	0.00014	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.25e-05	0.000139	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	1.24e-05	0.000138	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTGS2—urinary bladder cancer	1.23e-05	0.000137	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—EP300—urinary bladder cancer	1.21e-05	0.000135	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.19e-05	0.000133	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PTEN—urinary bladder cancer	1.19e-05	0.000133	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	1.19e-05	0.000133	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.16e-05	0.00013	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.16e-05	0.000129	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PPARG—urinary bladder cancer	1.15e-05	0.000128	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.15e-05	0.000128	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.15e-05	0.000128	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—EP300—urinary bladder cancer	1.14e-05	0.000128	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.14e-05	0.000127	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—EP300—urinary bladder cancer	1.14e-05	0.000127	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.12e-05	0.000125	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—SRC—urinary bladder cancer	1.11e-05	0.000124	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CREBBP—urinary bladder cancer	1.1e-05	0.000123	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.1e-05	0.000123	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.09e-05	0.000122	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.08e-05	0.000121	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.08e-05	0.00012	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GSTP1—urinary bladder cancer	1.08e-05	0.00012	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CDKN1A—urinary bladder cancer	1.07e-05	0.00012	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTEN—urinary bladder cancer	1.07e-05	0.000119	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.06e-05	0.000118	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.04e-05	0.000116	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PTGS2—urinary bladder cancer	1.03e-05	0.000115	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.02e-05	0.000114	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—EP300—urinary bladder cancer	1.02e-05	0.000114	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.01e-05	0.000113	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—TYMS—urinary bladder cancer	1e-05	0.000112	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	9.95e-06	0.000111	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—SRC—urinary bladder cancer	9.91e-06	0.000111	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GSTM1—urinary bladder cancer	9.89e-06	0.00011	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—NCOR1—urinary bladder cancer	9.89e-06	0.00011	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.8e-06	0.000109	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	9.75e-06	0.000109	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	9.66e-06	0.000108	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—EP300—urinary bladder cancer	9.49e-06	0.000106	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GPX1—urinary bladder cancer	9.47e-06	0.000106	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.34e-06	0.000104	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	9.33e-06	0.000104	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—ERCC2—urinary bladder cancer	9.3e-06	0.000104	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—KRAS—urinary bladder cancer	9.21e-06	0.000103	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PTGS2—urinary bladder cancer	9.03e-06	0.000101	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	8.98e-06	0.0001	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PTEN—urinary bladder cancer	8.95e-06	9.99e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.93e-06	9.97e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MYC—urinary bladder cancer	8.88e-06	9.91e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	8.87e-06	9.9e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	8.87e-06	9.9e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	8.81e-06	9.83e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—MTHFR—urinary bladder cancer	8.74e-06	9.75e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—EGFR—urinary bladder cancer	8.69e-06	9.7e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	8.64e-06	9.64e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	8.64e-06	9.64e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—EP300—urinary bladder cancer	8.54e-06	9.53e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.52e-06	9.51e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	8.51e-06	9.49e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	8.5e-06	9.48e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	8.38e-06	9.35e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	8.34e-06	9.31e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	8.23e-06	9.18e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—KRAS—urinary bladder cancer	8.21e-06	9.16e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	8.19e-06	9.13e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TP53—urinary bladder cancer	8.18e-06	9.13e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—EP300—urinary bladder cancer	8.11e-06	9.05e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	8.09e-06	9.03e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	8.09e-06	9.03e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	7.9e-06	8.82e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PTEN—urinary bladder cancer	7.88e-06	8.79e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	7.84e-06	8.75e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—HRAS—urinary bladder cancer	7.82e-06	8.73e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	7.75e-06	8.65e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	7.61e-06	8.49e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—EP300—urinary bladder cancer	7.51e-06	8.38e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	7.15e-06	7.98e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PPARG—urinary bladder cancer	7.09e-06	7.91e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HRAS—urinary bladder cancer	6.98e-06	7.78e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.96e-06	7.77e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CREBBP—urinary bladder cancer	6.81e-06	7.59e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	6.47e-06	7.22e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	6.36e-06	7.1e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	6.11e-06	6.82e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.81e-06	6.48e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	5.8e-06	6.47e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	5.64e-06	6.3e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTGS2—urinary bladder cancer	5.57e-06	6.22e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	5.57e-06	6.22e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.4e-06	6.02e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—EP300—urinary bladder cancer	5.38e-06	6.01e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.34e-06	5.96e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.34e-06	5.96e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.11e-06	5.7e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.02e-06	5.6e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	5e-06	5.58e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTEN—urinary bladder cancer	4.86e-06	5.42e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.72e-06	5.26e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—EP300—urinary bladder cancer	4.64e-06	5.17e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	4.56e-06	5.09e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	4.36e-06	4.87e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—EP300—urinary bladder cancer	4.16e-06	4.64e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.98e-06	4.44e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.82e-06	4.27e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.79e-06	4.23e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.67e-06	4.1e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.01e-06	3.36e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.62e-06	2.93e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.5e-06	2.79e-05	CbGpPWpGaD
